Navigation Links
Vasogen Announces 2007 Year-End Results
Date:1/16/2008

Deficit (381,783) (351,374)

-----------------------------------------------------------------------

23,356 24,580

$ 28,050 $ 41,770

-------------------------------------------------------------------------

-------------------------------------------------------------------------

VASOGEN INC.

(A DEVELOPMENT STAGE COMPANY)

Consolidated Statements of Operations, Deficit and Comprehensive Income

(In thousands of Canadian dollars, except per share amounts)

-------------------------------------------------------------------------

Period from

December 1,

1987 to

Years ended November 30, November 30,

2007 2006 2005 2007

-------------------------------------------------------------------------

Expenses:

Research and development $ 12,039 $ 32,732 $ 71,421 $ 238,917

General and

administration 14,259 19,251 22,126 117,228

Foreign exchange loss

(gain) 1,977 104 (719) 10,970

-------------------------------------------------------------------------

Loss before the undernoted (28,275) (52,087) (92,828) (367,115)

Interest expense on senior

convertible notes payable (5) (930) (344) (1,279)

Accretion in carrying value

of senior convertible

notes payable (728) (7,824) (1,742) (10,294)

Amortization of deferred

financ
'/>"/>

SOURCE Vasogen Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Vasogen Announces Third Quarter Conference Call and Webcast of Bio InvestorForum 2007 Presentation
2. Vasogen Announces Third Quarter 2007 Results
3. Vasogen to Webcast Presentations at Three Upcoming Healthcare Conferences
4. Vasogen Provides an Update on ACCLAIM-II Preparations
5. Vasogen and Grupo Ferrer Announce Initial Roll-out of Celacade - New Therapy for Chronic Heart Failure
6. Vasogen to Conduct Year-end 2007 Conference Call
7. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
8. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
9. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
10. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
11. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... Research Triangle Park, NC (PRWEB) March 05, 2015 ... Entegrion, Inc., announced that Pierre Noel, M.D., Professor ... been elected to the Company’s Board of Directors. ... Mowell said, “We are extremely fortunate to have ... with the country’s leading healthcare organization, join Entegrion’s ...
(Date:3/5/2015)... , March 5, 2015  In response to ... Miami, FL on February 12, ... both of strong financial health and their SUDOSCAN® devices ... research has indicated. Furthermore, Impeto prefers to have the courts ... There are more than 40 articles written by Key ...
(Date:3/4/2015)... 2015 PDL BioPharma, Inc. (PDL) (NASDAQ: ... the: , 3.75% Convertible Senior Notes due May ... stock per $1,000 principal amount or approximately $5.72 per share, ... the note is adjusted in connection with the regular quarterly ... all stockholders who own shares of PDL on March 5, 2015, ...
(Date:3/4/2015)... (PRWEB) March 04, 2015 USDM ... in the life sciences industry, hired David Blewitt ... the Cloud Compliance Services and Solutions at USDM ... cloud based applications while maintaining compliance with government regulations ... has been an accomplished life sciences regulatory and IS ...
Breaking Biology Technology:Entegrion Announces Appointment of Pierre Noel, MD, to Its Board of Directors 2Impeto Medical Responds to Published Allegations by LD Technology LLC ("LD") 2PDL BioPharma Announces Conversion Rate Adjustment for Convertible Note 2USDM Life Sciences Names David Blewitt VP of Cloud Compliance for Regulated Life Sciences 2USDM Life Sciences Names David Blewitt VP of Cloud Compliance for Regulated Life Sciences 3
... in medical device industry to benefit ... pharmaceutical clinical trial recruitment efforts, MINNEAPOLIS, May ... firm ThreeWire has strengthened the,pharmaceutical side of its ... development and a commitment to leveraging differentiators unique,to ...
... 27 Schering-Plough,Corporation (NYSE: SGP ) ... been,appointed vice president, investor relations, effective immediately., ... responsible for developing, implementing,and continually improving a ... will lead the formulation and execution of,external ...
... Collagen Matrix, Inc.,announced today that it has ... clearance of its TenoMend(TM) Collagen Tendon Wrap,indicated for ... which,there has been no substantial loss of tendon ... resorbable type 1 collagen,matrix that provides a non-constricting ...
Cached Biology Technology:ThreeWire Expands Presence in the Pharmaceutical Arena 2Schering-Plough Appoints Janet M. Barth Vice President, Investor Relations 2Collagen Matrix, Inc. Receives FDA 510(k) Clearance for TenoMend(TM) Collagen Tendon Wrap for the Management and Protection of Tendon Injuries 2
(Date:2/5/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD ... company focused on the growing mobile commerce market, announces ... ) as part of its 2015 marketing and branding ... its new consumer website for Wocketwallet.com earlier this month. ... NXT-ID said, "Our new corporate website naturally showcases our ...
(Date:2/5/2015)... SAN FRANCISCO , January 28, 2015 ... Camera Market Analysis, Size And Segment Forecasts To 2020 ... The global IR camera market is expected to reach ... study by Grand View Research, Inc. IR cameras help ... injuries, and are expected to witness surging demand in ...
(Date:2/5/2015)... Jan. 28, 2015 Research and Markets ... of the "Global Biometrics Market (2014-2020): Market ... Countries " report to their offering. , ... Asia-Pacific is anticipated to overtake ... to increasing government spending towards IT security, government ...
Breaking Biology News(10 mins):NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 2NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 3IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 2IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 3Global Biometrics Market (2014-2020): Market Forecast By Technologies, Applications, End Use, Regions and Countries 2Global Biometrics Market (2014-2020): Market Forecast By Technologies, Applications, End Use, Regions and Countries 3
... A new poisonous frog was recently discovered in a ... young scientists supported by the Conservation Leadership Programme (CLP). ... length, was given the name the ?golden frog of ... was similar to several other common species in the ...
... in the Western world. The tumor starts off as a ... which often spreads to the liver. In an article recently ... Dr. Nancy Gavert of the Weizmann Institutes Molecular Cell Biology ... a majority of cases, colorectal cancer is initiated by changes ...
... ever discovered DNA from living bacteria that are more than ... still living organisms that old been found. The exceptional discovery ... cells and might even cast light on the question of ... current issue of PNAS (Proceedings of The National Academy of ...
Cached Biology News:A gene for metastasis 2The world's oldest bacteria 2
...
Mouse monoclonal antibody raised against a partial recombinant PUM2. NCBI Entrez Gene ID = PUM2...
... Cloning Kit enables you to prepare, in ... primary cosmid library of genomic DNA for ... High efficiency cosmid library construction is accomplished ... First, genomic DNA is randomly sheared by ...
... clear polystyrene with frosted labeling surfaces, ... cell counting. 100% integrity tested. Linkage: ... product number, created to easily match ... availability yet, please order under the ...
Biology Products: